Barclays’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$231M Buy
594,274
+90,842
+18% +$35.3M 0.05% 193
2025
Q1
$219M Buy
503,432
+54,352
+12% +$23.6M 0.06% 187
2024
Q4
$166M Sell
449,080
-172,004
-28% -$63.5M 0.05% 195
2024
Q3
$323M Sell
621,084
-368,538
-37% -$192M 0.09% 146
2024
Q2
$536M Sell
989,622
-35,466
-3% -$19.2M 0.16% 73
2024
Q1
$532M Sell
1,025,088
-209,835
-17% -$109M 0.18% 81
2023
Q4
$582M Buy
1,234,923
+142,245
+13% +$67.1M 0.21% 66
2023
Q3
$476M Sell
1,092,678
-170,723
-14% -$74.3M 0.3% 61
2023
Q2
$561M Buy
1,263,401
+437,225
+53% +$194M 0.36% 51
2023
Q1
$380M Buy
826,176
+46,111
+6% +$21.2M 0.17% 43
2022
Q4
$400M Buy
780,065
+327,413
+72% +$168M 0.18% 59
2022
Q3
$206M Buy
452,652
+104,400
+30% +$47.4M 0.22% 94
2022
Q2
$168M Sell
348,252
-134,530
-28% -$64.9M 0.1% 123
2022
Q1
$237M Sell
482,782
-169,204
-26% -$83.1M 0.19% 118
2021
Q4
$302M Buy
651,986
+21,222
+3% +$9.84M 0.11% 121
2021
Q3
$235M Buy
630,764
+115,734
+22% +$43.1M 0.11% 118
2021
Q2
$197M Buy
515,030
+59,614
+13% +$22.8M 0.09% 135
2021
Q1
$163M Buy
455,416
+81,965
+22% +$29.4M 0.09% 141
2020
Q4
$120M Buy
373,451
+58,659
+19% +$18.8M 0.06% 158
2020
Q3
$84.6M Buy
314,792
+57,016
+22% +$15.3M 0.05% 183
2020
Q2
$67.8M Sell
257,776
-23,270
-8% -$6.12M 0.05% 181
2020
Q1
$63.8M Sell
281,046
-191,373
-41% -$43.4M 0.05% 167
2019
Q4
$143M Sell
472,419
-93,463
-17% -$28.2M 0.08% 132
2019
Q3
$136M Sell
565,882
-74,406
-12% -$17.9M 0.09% 128
2019
Q2
$181M Buy
640,288
+136,580
+27% +$38.5M 0.11% 103
2019
Q1
$145M Buy
503,708
+131,700
+35% +$37.8M 0.1% 110
2018
Q4
$97.7M Sell
372,008
-47,569
-11% -$12.5M 0.08% 130
2018
Q3
$115M Sell
419,577
-66,956
-14% -$18.3M 0.08% 126
2018
Q2
$116M Sell
486,533
-129,719
-21% -$30.9M 0.1% 108
2018
Q1
$135M Buy
616,252
+150,039
+32% +$33M 0.1% 117
2017
Q4
$105M Buy
466,213
+121,716
+35% +$27.4M 0.09% 130
2017
Q3
$65.4M Sell
344,497
-70,697
-17% -$13.4M 0.07% 146
2017
Q2
$78.1M Sell
415,194
-17,444
-4% -$3.28M 0.08% 112
2017
Q1
$71.5M Buy
432,638
+165,733
+62% +$27.4M 0.08% 116
2016
Q4
$38.4M Buy
266,905
+9,829
+4% +$1.41M 0.04% 193
2016
Q3
$32.2M Sell
257,076
-173,856
-40% -$21.8M 0.04% 200
2016
Q2
$56.6M Buy
430,932
+144,214
+50% +$18.9M 0.07% 119
2016
Q1
$39.6M Buy
286,718
+51,358
+22% +$7.09M 0.06% 159
2015
Q4
$32.7M Buy
235,360
+67,099
+40% +$9.33M 0.04% 207
2015
Q3
$23.6M Sell
168,261
-147,658
-47% -$20.7M 0.03% 264
2015
Q2
$51.8M Sell
315,919
-58,532
-16% -$9.6M 0.06% 154
2015
Q1
$57.7M Buy
374,451
+36,218
+11% +$5.58M 0.07% 164
2014
Q4
$42.3M Sell
338,233
-134,796
-28% -$16.8M 0.04% 217
2014
Q3
$56.3M Sell
473,029
-776
-0.2% -$92.3K 0.05% 159
2014
Q2
$50.7M Sell
473,805
-105,079
-18% -$11.2M 0.05% 177
2014
Q1
$57.3M Sell
578,884
-127,531
-18% -$12.6M 0.06% 158
2013
Q4
$65M Buy
706,415
+65,292
+10% +$6.01M 0.07% 156
2013
Q3
$53.2M Buy
641,123
+72,763
+13% +$6.04M 0.06% 152
2013
Q2
$46.5M Buy
+568,360
New +$46.5M 0.06% 154